|
|
||||||||
Clinical Chemistry, Vol 39, 1804-1810, Copyright © 1993 by American Association for Clinical Chemistry
DW Jay and D Provasek
Department of Pathology and Laboratory Medicine, Texas A&M University College of Medicine, Temple.
The effect of hemolysis on several assays performed with the Hitachi 717 was quantified by relating the amount of error to the concentration of hemoglobin. Hemolysis interference was judged clinically significant when analyte concentration varied by > 10% from the initial value. Hemolysis interference was significant for alkaline phosphatase, aspartate aminotransferase, alpha-amylase, bilirubin, creatine kinase, gamma-glutamyltransferase, lactate dehydrogenase, lactate dehydrogenase- 1, potassium, and theophylline assays. Error (expressed in absolute terms) was linearly dependent on hemoglobin concentration and independent of the initial analyte concentration in each case, except for bilirubin and theophylline, where multiple regression analysis was required to quantify the effect. Relative error was dependent on the initial analyte concentration in all cases. Correction formulas were calculated from linear regression of absolute error vs hemoglobin concentration. Clinical application of correction formulas and mechanisms of hemolysis interference for each assay are discussed.
The following articles in journals at HighWire Press have cited this article:
![]() |
F. M. Yilmaz and D. Yucel Effect of Addition of Hemolysate on Urine and Cerebrospinal Fluid Assays for Protein Clin. Chem., January 1, 2006; 52(1): 152 - 153. [Full Text] [PDF] |
||||
![]() |
H. J. Vermeer, E. Thomassen, and N. de Jonge Automated Processing of Serum Indices Used for Interference Detection by the Laboratory Information System Clin. Chem., January 1, 2005; 51(1): 244 - 247. [Full Text] [PDF] |
||||
![]() |
C. Gay-Bellile, D. Bengoufa, P. Houze, D. Le Carrer, M. Benlakehal, B. Bousquet, B. Gourmel, and T. Le Bricon Automated Multicapillary Electrophoresis for Analysis of Human Serum Proteins Clin. Chem., November 1, 2003; 49(11): 1909 - 1915. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hawkins Variability in Potassium/Hemoglobin Ratios for Hemolysis Correction Clin. Chem., May 1, 2002; 48(5): 796 - 796. [Full Text] [PDF] |
||||
![]() |
S. C. Kazmierczak, P. G. Catrou, and D. Boudreau Simplified interpretative format for assessing test interference: studies with hemoglobin-based oxygen carrier solutions Clin. Chem., November 1, 1998; 44(11): 2347 - 2352. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Y. Ali, C. C. Mihas, and J. A. Campbell Interferences of o-raffinose cross-linked hemoglobin in three methods for serum creatinine Clin. Chem., September 1, 1997; 43(9): 1738 - 1743. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Y. Ali and J. A. Campbell Interference of o-Raffinose Cross-Linked Hemoglobin with Routine Hitachi 717 Assays Clin. Chem., September 1, 1997; 43(9): 1794 - 1796. [Full Text] |
||||
![]() |
C. M. Balion, P. A. Champagne, and A. C. Y. Ali Evaluation of HemogloBindTM for Removal of o-Raffinose Cross-Linked Hemoglobin (HemolinkTM) from Serum Clin. Chem., September 1, 1997; 43(9): 1796 - 1798. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |